Evoke Pharma (EVOK) Tops Q2 EPS by 17c

Evoke Pharma (NASDAQ: EVOK) reported Q2 EPS of ($0.56), $0.17 better than the analyst estimate of ($0.73). Revenue for the quarter came in at $1.13 million versus the consensus estimate of $1.1 million.

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• Goldman Sachs reports global fund inflows for week of July 8
• Wells Fargo previews Q2 midstream earnings, favors PAA and TRGP